02-Nov-2010 - Agilent Technologies has opened a new instrument plant in Singapore to boost capacity for LC/MS production and drive expansion across Asia.
27-Oct-2010 - The FDA may never have inspected 88 per cent of the 920 Chinese facilities in its inventory, according to the GAO.
26-Oct-2010 - Rx-360 expects membership numbers to “snowball” in the coming year as it looks to build on progress made in establishing the consortium.
25-Oct-2010 - The United States Pharmacopeial Convention (USP) and six government drug control laboratories in the Middle East and Northern Africa (MENA) join to launch a drug quality improvement Network.
25-Oct-2010 - Sanyo Biomedical is launching a cost-effective, space-saving stand-alone cell processing work station (CPWS) for GMP production.
21-Oct-2010 - A developmental purification system for Antibody-Drug-Conjugates will be launched by ADC Biotechnology (ADBC), a spin off from Reaxa, which promises reduced manufacturing costs for “magic bullet” cancer drugs.
21-Oct-2010 - The WHO is today initiating a pilot prequalification programme for selected APIs used in drugs for HIV and related diseases, antimalarials and anti-tuberculosis medications.
21-Oct-2010 - Bio-Research Products (BRP) launches lower cost, industrial chloroperoxidase (CPO) for organic syntheses in pharmaceutical manufacturing.
20-Oct-2010 - in-PharmaTechnologist presents a round up of cGMP related warning letters issued by the FDA this week.
20-Oct-2010 - Johnson & Johnson (J&J) recalls another 128,000 bottles of its over-the-counter painkiller, Tylenol, after new complaints of a “mouldy odour.”
19-Oct-2010 - Industrial catalysis firm WR Grace has been OKed to acquire fine chemicals group Synthetech by the US Bankruptcy Court.
19-Oct-2010 - Prosonix expects high demand for innovative particle processing technologies in the $24bn (€17bn) a-year respiratory pharmaceuticals market over the next few years.
14-Oct-2010 - Baxter International will combine its delivery business, which supplies IV infusion systems and intravenous solutions, with its renal products unit in new Medical products division.
14-Oct-2010 - The FDA is to collaborate with the WHO to build a global surveillance and monitoring system for combating falsified medicines and breaches of the supply chain.
13-Oct-2010 - Pharmatek Laboratories has once again expanded service offerings at its San Diego, California facility by adding two roller compactors to its solid oral dosage form manufacturing capabilities.
13-Oct-2010 - New ‘chiral center’ in Belgium promises to help drug firms comply with regulatory demands for quality and accelerate registration of new compounds.
13-Oct-2010 - “Musty smells” associated with three Lipitor bottles indicate a problem within the supply chain, says Rexam of Las Piedras, Puerto Rico, who were confirmed by Pfizer as the “third-party recalling supplier.”
12-Oct-2010 - Guy Villax, board member of the EFCG, talks falsified APIs, EU efforts to tackle the issue, and the presence of gangsters in the pharma industry in an in-PharmaTechnologist video interview.
11-Oct-2010 - Pfizer says low levels of 2,4,6 tribromoanisole were detected in seven lots of the cholesterol buster, Lipitor, that it recalled in August.
05-Oct-2010 - Gilead Sciences has received a warning letter from the US Food and Drug Administration (FDA) concerning manufacturing problems at the San Dimas, California, plant, where HIV medicines are made.
30-Sep-2010 - SP Scientific is combining its lyophilisation equipment with ControLyo from Praxair to enable precise control over the freeze-drying process.
28-Sep-2010 - RTS Life Science has formed a Pharmaceutical Testing Group to integrate UK developed products for inhaler and tablet testing with US developed products for dissolution and content uniformity testing.
23-Sep-2010 - Oracle is revising its lifecycle management package to streamline processes including scale-up to commercial production and QbD implementation.
21-Sep-2010 - Pall is launching the GeneDisc Rapid Microbiology System for quicker microbial quality monitoring and improved production efficiency.
20-Sep-2010 - Life Technologies has concluded license agreements, providing rights to its proprietary Chinese hamster ovary (CHO) cell lines for production of recombinant proteins used as therapeutic agents and vaccines.